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Introduction 
Radiation treatment (RT) is widely used in childhood cancer (CC) treatment. The relation 
between radiation dose and late adverse effects is studied to enable the design of the least 
toxic, yet effective RT plan. The challenge for 3D dose reconstruction of historically treated 
patients with long-term follow-up is the absence of 3D CT scans, because at the time of 
treatment 2D simulator films were used. To solve this problem, phantom-based dose 
reconstruction methods have been developed. The phantom’s anatomical structure is 
generally based on CT scans of patients of a certain gender/age [1]. However, being a general 
representative of patients with matched gender/age, the phantom does not represent true 
individual patient anatomies. A key question is therefore whether anatomical variations across 
gender/age matched paediatric patients lead to significant differences in dose calculation 
outcomes. To answer this question, we studied the variation in reconstructed dose among 
gender/age matched patients when the same RT plan was applied to them. 
Materials & Methods 
Ten 3-year-old CC patients, five males and five females, were treated from 2009 to 2015, with 
CT scans of the abdomen available. Patients’ ages at start of RT ranged from 3.02–3.98 and 
3.01–3.67 years for females and males respectively. Since the majority of the patients (8/10) 
were treated for Wilms’ tumor, we focussed on this site and retrieved the corresponding eight 
RT plans. The RT plan, dose, and CT of each of these eight patients were used as references. 
Note, all ten CT scans were used for dose reconstruction. We applied each reference RT plan 
to the other patients’ CT scans in the gender/age matched group, maintaining the RT plan 
isocenter position relative to the spinal cord in all directions, without changing field size and 
other beam settings. For dose comparison liver, spleen, left kidney, and spinal cord were 
delineated by an expert following clinical protocols. For the differences between 
reconstructed and reference dose, we first compared the relative difference in minimum, 
maximum, mean, and median organ dose (normalized by reference dose at isocenter). Next, 
gamma (γ) analysis was used to assess 3D organ dose distribution differences [2]. To compare 
the reconstructed doses to the reference dose, organs were first deformably registered with 
Elastix [3]. Two different settings for the distance-to-agreement acceptance and the dose-
difference (defined as % of maximum dose) criteria were used (i.e., S1: 5mm, 5%; S2: 10mm, 
10%) to calculate the γ-values and fraction of passed γ-values. Voxel values <10% of 
maximum dose were ignored. The fraction of passed γ-values (i.e., γ <1) to an organ indicates 
the percentage of voxels of the organ passing the two criteria.  
Results 
For every organ and for every dose metric, the average relative deviation is <30%, but the 
maximum deviation is much higher, e.g., reaching 150% for the deviation in minimum dose 
18th International Conference on the use of Computers in Radiation Therapy 
[page number] 
to the left kidney (Fig. 1). Further, the difference between dose-volume histograms (DVH) of 
reconstructed doses and the DVH of the reference plan varies substantially over reference 
plans (Fig. 2). Average pass fractions (PF), average γ-values, and the percentage of 
comparisons with PF<80%, are given in Table 1. The two settings have a different strictness 
of acceptance criteria (i.e., S2 less strict than S1), thus the results differ. Although for the left 
kidney S1 and S2 provide similar average γ-values, for the liver and spleen a difference of a 
factor ~2 is found. The percentage of plans with PF<80% ranges from 12% to 75%. This 
indicates that the probability that >20% of the voxels fail the acceptance criteria is not small. 
Discussion & Conclusions 
The results of the dose reconstruction method based on CT scans of gender/age matched CC 
patients show good accuracy in terms of average dose metrics. However, the remaining dose 
comparisons indicate that the method is not yet sufficiently robust and accurate. Thus, only 
using gender and age as criteria to group patients and randomly selecting one representative 
without adjusting the field size when applying RT plans does not guarantee sufficient 
accuracy. We are currently investigating alternatives with potentially better accuracy. 
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Figure 1: Organ dose metric deviations 
(dev), maximum and average values. 
 
 
Figure 2 (right):  DVHs of reference and 
reconstructed doses at spleen, for two 
different plans (denoted as example 1 and 
example 2, respectively). 
Organ Liver Spleen Left kidney 
Setting S1 S2 S1 S2 S1 S2 
Avg PF (%) 66 85 73 88 90 93 
Avg γ 1.06
6 
0.53 0.74 0.37 0.29 0.24 
% PF < 80% 75 12 50 38 25 19 
Table 1:  Average pass fraction and γ-value of all 
reconstructed dose distributions under two criteria 
settings (S1 and S2), and % of plans with PF < 80%. 
 
